You are here

Docket Number 3065

Received: 
Thursday, April 16, 2015
Commodity: 
Recombinant Factor VIII Products
Investigation Number: 
337-TA-956
Filed By: 
Tom M. Schaumberg
Firm/Organization: 
Adduci, Mastriani, & Schaumberg LLP
Behalf Of: 
Baxter International Inc., Baxter Healthcare Corporation, and Baxter Healthcare SA.
Confidential: 
Yes
Country: 
None
Description: 
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Recombinant Factor VIII Products. The proposed respondents are Novo Nordisk A/S, Denmark and Novo Nordisk Inc., Plainsboro, New Jersey.